CHO cells for virus-like particle and subunit vaccine manufacturing, Vaccine, 42, 10, (2530-2542), (2024).https://doi.org/10.1016/j.vaccine.2024.03.034.
CHO cells for virus-like particle and subunit vaccine manufacturing https://t.co/3ziwa103AC
Mentions
Extended reach
Total likes
Video views
AI synopsis
The posts reflect a balanced view, highlighting the potential of CHO cells in vaccine development, with phrases like 'exciting advancements' and '#CHOcells #Bioprocess' demonstrating moderate enthusiasm and recognition of significance. The tone is mostly optimistic yet concise, indicating a general awareness of the topic's importance without deep technical debate.
The posts seem generally positive and supportive of the research developments, indicating mild to moderate agreement.
Discussion points show some curiosity about the advancements in CHO cell technology and vaccine production, though not intensely detailed.
The posts are brief and lack deep analysis but acknowledge the importance of the advancements.
The postings imply that this research could influence vaccine manufacturing practices, though the discussion remains surface-level.
CHO cells for virus-like particle and subunit vaccine manufacturing https://t.co/3ziwa103AC
CHO cells, traditionally used for manufacturing monoclonal antibodies, are now increasingly employed for vaccine antigen production, including subunit and virus-like particle vaccines for RSV, VZV, and HBV. Recent…
Chinese Hamster Ovary cells are increasingly used for vaccine antigen production, including subunit vaccines for RSV and VZV, and virus-like particles for HBV. Recent progress highlights their potential and ongoing…
CHO cells for virus-like particle and subunit vaccine manufacturing. Vaccine(2024) #CHOcells #Bioprocess https://t.co/M1rTjcNPQt
CHO cells for virus-like particle and subunit vaccine manufacturing https://t.co/3ziwa103AC
CHO cells for virus-like particle and subunit vaccine manufacturing, Vaccine, 42, 10, (2530-2542), (2024).https://doi.org/10.1016/j.vaccine.2024.03.034.
Exacerbations. Chest. 2024 Aug;166(2):294-303. doi: 10.1016/j.chest.2024.03.034 95% CI, 0.61 ...
in vaccine development is less widespread compared treatment. ITM ... doi: 10.1016/j.jaip.2024.03.034. and validation of blood-based ...
... CHO cells as substrates to produce recombinant protein-based vaccines Go check it out here! https://lnkd.in/gFvppGmt.